DNLI
Price
$11.72
Change
-$1.07 (-8.37%)
Updated
Apr 4, 04:11 PM (EDT)
Capitalization
1.86B
39 days until earnings call
TIL
Price
$15.00
Change
-$1.63 (-9.80%)
Updated
Apr 4, 04:31 PM (EDT)
Capitalization
119.55M
Ad is loading...

DNLI vs TIL

Header iconDNLI vs TIL Comparison
Open Charts DNLI vs TILBanner chart's image
Denali Therapeutics
Price$11.72
Change-$1.07 (-8.37%)
Volume$1.08K
Capitalization1.86B
Instil Bio
Price$15.00
Change-$1.63 (-9.80%)
Volume$400
Capitalization119.55M
DNLI vs TIL Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. TIL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and TIL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DNLI: $12.79 vs. TIL: $16.63)
Brand notoriety: DNLI and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 123% vs. TIL: 89%
Market capitalization -- DNLI: $1.86B vs. TIL: $119.55M
DNLI [@Biotechnology] is valued at $1.86B. TIL’s [@Biotechnology] market capitalization is $119.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, TIL is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while TIL’s TA Score has 2 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 3 bearish.
  • TIL’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than TIL.

Price Growth

DNLI (@Biotechnology) experienced а -9.93% price change this week, while TIL (@Biotechnology) price change was -14.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.19%. For the same industry, the average monthly price growth was -17.05%, and the average quarterly price growth was -18.79%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

TIL is expected to report earnings on Mar 04, 2024.

Industries' Descriptions

@Biotechnology (-11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($1.86B) has a higher market cap than TIL($120M). TIL YTD gains are higher at: -12.886 vs. DNLI (-37.242). TIL has higher annual earnings (EBITDA): -62.53M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. TIL (113M). DNLI has less debt than TIL: DNLI (48.7M) vs TIL (86.9M). DNLI (0) and TIL (0) have equivalent revenues.
DNLITILDNLI / TIL
Capitalization1.86B120M1,548%
EBITDA-492.89M-62.53M788%
Gain YTD-37.242-12.886289%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M113M736%
Total Debt48.7M86.9M56%
FUNDAMENTALS RATINGS
DNLI vs TIL: Fundamental Ratings
DNLI
TIL
OUTLOOK RATING
1..100
6965
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
8860
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (16) in the Precious Metals industry is significantly better than the same rating for DNLI (94) in the Biotechnology industry. This means that TIL’s stock grew significantly faster than DNLI’s over the last 12 months.

TIL's Profit vs Risk Rating (95) in the Precious Metals industry is in the same range as DNLI (100) in the Biotechnology industry. This means that TIL’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (95) in the Biotechnology industry is in the same range as TIL (97) in the Precious Metals industry. This means that DNLI’s stock grew similarly to TIL’s over the last 12 months.

TIL's Price Growth Rating (60) in the Precious Metals industry is in the same range as DNLI (88) in the Biotechnology industry. This means that TIL’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's P/E Growth Rating (98) in the Biotechnology industry is in the same range as TIL (100) in the Precious Metals industry. This means that DNLI’s stock grew similarly to TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLITIL
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 19 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALPCX10.54N/A
N/A
American Century Focused Lg Cap Val C
GSQRX30.81N/A
N/A
Goldman Sachs Small Cap Value R
MACEX12.86N/A
N/A
Martin Currie Emerging Markets A
TRHZX149.08N/A
N/A
T. Rowe Price Equity Index 500 Z
MIIOX25.32N/A
N/A
Marsico International Opportunities Inst